Drug helps 96% beat testicular cancer
Figures published yesterday by the Cancer Research UK organisation showed survival rates for testicular cancer have now risen to more than 96%. That represents an increased survival rate of almost 30% compared with the 1970s.
Cancer experts attributed much of the increased survival rate to the use of a chemotherapy drug called Cisplatin, also used for bladder, lung, and ovarian cancers.
